DK1299388T3 - Variolin-derivater som anti-cancermidler - Google Patents

Variolin-derivater som anti-cancermidler

Info

Publication number
DK1299388T3
DK1299388T3 DK01949663T DK01949663T DK1299388T3 DK 1299388 T3 DK1299388 T3 DK 1299388T3 DK 01949663 T DK01949663 T DK 01949663T DK 01949663 T DK01949663 T DK 01949663T DK 1299388 T3 DK1299388 T3 DK 1299388T3
Authority
DK
Denmark
Prior art keywords
sub
substituted
group
unsubstituted
variolin
Prior art date
Application number
DK01949663T
Other languages
Danish (da)
English (en)
Inventor
Jonathan Charles Morris
Regan James Anderson
Modesto Remuinan
Ignacio Manzanares
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0017055A external-priority patent/GB0017055D0/en
Priority claimed from GB0030689A external-priority patent/GB0030689D0/en
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Application granted granted Critical
Publication of DK1299388T3 publication Critical patent/DK1299388T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK01949663T 2000-07-11 2001-07-11 Variolin-derivater som anti-cancermidler DK1299388T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0017055A GB0017055D0 (en) 2000-07-11 2000-07-11 Synthesis
GB0030689A GB0030689D0 (en) 2000-12-15 2000-12-15 Synthesis
PCT/GB2001/003111 WO2002004447A1 (en) 2000-07-11 2001-07-11 Variolin derivatives as anti-cancer agents

Publications (1)

Publication Number Publication Date
DK1299388T3 true DK1299388T3 (da) 2009-08-31

Family

ID=26244637

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01949663T DK1299388T3 (da) 2000-07-11 2001-07-11 Variolin-derivater som anti-cancermidler

Country Status (20)

Country Link
US (1) US7320981B2 (es)
EP (1) EP1299388B1 (es)
JP (1) JP2004502773A (es)
KR (1) KR100886161B1 (es)
CN (1) CN1324028C (es)
AT (1) ATE431349T1 (es)
AU (3) AU2001270783B2 (es)
BR (1) BR0112413A (es)
CA (1) CA2414200C (es)
CY (1) CY1109283T1 (es)
DE (1) DE60138707D1 (es)
DK (1) DK1299388T3 (es)
ES (1) ES2327210T3 (es)
IL (2) IL153682A0 (es)
MX (1) MXPA03000341A (es)
NZ (1) NZ523491A (es)
PT (1) PT1299388E (es)
RU (1) RU2299884C2 (es)
SI (1) SI1299388T1 (es)
WO (1) WO2002004447A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0019117D0 (en) * 2000-08-03 2000-09-27 Univ Barcelona Derivatives of variolin B
GB0116966D0 (en) 2001-07-11 2001-09-05 Pharma Mar Sa Anittumoral compounds
DE10260235B4 (de) 2002-12-20 2010-10-28 Infineon Technologies Ag Verfahren zum Strukturieren einer Resistschicht und Negativ-Resistschicht
WO2004110990A2 (en) 2003-05-15 2004-12-23 Arqule, Inc. Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38
WO2006010082A1 (en) 2004-07-08 2006-01-26 Arqule, Inc. 1,4-disubstituted naphtalenes as inhibitors of p38 map kinase
EP1809636A1 (en) 2004-10-19 2007-07-25 Arqule, Inc. Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
EP1666467A1 (en) * 2004-11-08 2006-06-07 Evotec AG 11Beta-HSD1 Inhibitors
EP1837373B1 (en) * 2005-01-12 2019-03-13 Kuraray Co., Ltd. Resin composition and film made of same
MX2007014327A (es) * 2005-05-16 2008-02-11 Irm Llc Derivados de pirrolopiridina como inhibidores de cinasa de proteina.
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0019117D0 (en) 2000-08-03 2000-09-27 Univ Barcelona Derivatives of variolin B
GB0116966D0 (en) 2001-07-11 2001-09-05 Pharma Mar Sa Anittumoral compounds

Also Published As

Publication number Publication date
WO2002004447A1 (en) 2002-01-17
AU7078301A (en) 2002-01-21
EP1299388A1 (en) 2003-04-09
ES2327210T3 (es) 2009-10-27
AU2006213946A1 (en) 2006-10-05
CA2414200C (en) 2010-05-04
ATE431349T1 (de) 2009-05-15
MXPA03000341A (es) 2004-04-05
AU2006213946B2 (en) 2008-01-10
AU2001270783B2 (en) 2006-06-15
US20050014778A1 (en) 2005-01-20
IL153682A (en) 2010-05-31
DE60138707D1 (de) 2009-06-25
CN1324028C (zh) 2007-07-04
EP1299388B1 (en) 2009-05-13
CA2414200A1 (en) 2002-01-17
US7320981B2 (en) 2008-01-22
RU2299884C2 (ru) 2007-05-27
IL153682A0 (en) 2003-07-06
KR20030017581A (ko) 2003-03-03
JP2004502773A (ja) 2004-01-29
BR0112413A (pt) 2003-05-27
CY1109283T1 (el) 2014-07-02
PT1299388E (pt) 2009-08-13
SI1299388T1 (sl) 2009-12-31
KR100886161B1 (ko) 2009-02-27
CN1630658A (zh) 2005-06-22
NZ523491A (en) 2004-06-25

Similar Documents

Publication Publication Date Title
CY1109283T1 (el) Παραγωγα βαριολινης ως αντικαρκινικα μεσα
JO2925B1 (en) New pyridine derivatives and pyrimidine derivatives (3)
NO20012617D0 (no) Kinolin- og kinzolinderivater
CY1108313T1 (el) Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6
UY26899A1 (es) Derivados de pirazol fusionados
MA18694A1 (fr) Nouveaux derives de piperidinyl alkyl-quinazoline
NO20034595D0 (no) Kinolin- og kinazolinderivater med azolylgruppe
DK1117297T3 (da) Syntetiske analoger af ecteinascidin-743
CY1109345T1 (el) ΠΑΡΑΓΩΓΑ ΥΠΟΚΑΤΕΣΤΗΜΕΝΗΣ 8-ΥΠΕΡΦΘΟΡΟΑΛΚΥΛΟ-6,7,8,9-ΤΕΤΡΑΫΔΡΟΠΥΡΙΜΙΔΟ (1,2-a) ΠΥΡΙΜΙΔΙΝ-4-ΟΝΗΣ
EA200600333A1 (ru) Производные индазола
ATE325796T1 (de) Derivate von triazolyl-imidazopyridine und von triazolylpurine als ligande des adenosine a2a rezeptoren und ihre verwendung als medicamente
EA200301317A1 (ru) Производные аминохинолина и его применение в качестве лигандов аденозина a3
DE69910568D1 (de) Furopyridinderivate und ihre therapeutische verwendung
SE0101651L (sv) Syntes och utvärdering av nya cyaninfärgämnen som binder till minor groove
DE60237652D1 (de) Variolinderivate und ihre Verwendung als Cytostatika
ATE364603T1 (de) Totalsynthese von myriaporonen
CO5140090A1 (es) Derivados de pirazol, su preparacion y su aplicacion en terapeutica
AR039175A1 (es) Derivados de morfolina, antagonistas de ccr3
ATE420855T1 (de) 2-substituierte vitamin-d-derivate
TH79781A (th) อนุพันธ์ไพราโซล
TW200621247A (en) Pyridine derivatives